Skip to main content
Log in

3-Hydroxymorphinan protects against hypoxia-induced cell death in primary astrocyte by regulating Ca2+ influx and the glutamate homeostasis

  • Original Article
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Background

Hypoxia is a pathological phenomenon of the central nervous system that occurs during ischemia and stroke, leading to brain cell damage. Astrocytes play an important role in maintaining homeostasis in the brain microenvironment under normal as well as in pathological conditions. 3-hydroxymorphinan (3-HM) is an active metabolite of dextromethorphan (DM) that is widely used in anti-cough remedies and is more potent and safer than DM in the treatment of neurological disorders. However, previous research has not examined whether 3-HM has a protective effect in ischemic condition.

Objective

In this study, we aimed to confirm the effect of 3-HM on hypoxia-induced astrocyte death. We also investigated the protective mechanism of 3-HM and its potential applicability in ischemia brain injury.

Result

For the in vitro hypoxic conditions, CoCl2, a hypoxia-mimetic agent, was added to mouse primary astrocytes. 200 μM of CoCl2 showed cytotoxicity, whereas pre-incubation with 3-HM attenuated cell death by CoCl2. Moreover, pre-treatment with 3-HM dramatically reduced oxidative stress and mitochondrial damage by CoCl2. Further, 3-HM significantly reduced intracellular calcium influx induced by extracellular glutamate and finally modulated the glutamate released from the astrocytes.

Conclusion

Taken together, these results suggest that 3-HM has a potential to regulate glutamate release from the astrocytic cell death in hypoxic condition and could be used as a promising preventive or therapeutic agent for ischemic brain injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1–14

    Article  CAS  PubMed  Google Scholar 

  • Chamorro Á, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15:869–881

    Article  CAS  PubMed  Google Scholar 

  • Choi DW (1987) Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res 403:333–336

    Article  CAS  PubMed  Google Scholar 

  • Dietz AG, S AG, Nedergaard M (2020) Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry 7:272–281

    Article  PubMed  Google Scholar 

  • Görlach A, Bertram K, Hudecova S, Krizanova O (2015) Calcium and ROS: a mutual interplay. Redox Biol 6:260–271

    Article  PubMed  PubMed Central  Google Scholar 

  • Habib N, Cristin McCabe S, Medina M, Varshavsky D, Kitsberg R, Dvir-Szternfeld G, Green D, Dionne L, Nguyen JL, Marshall F, Chen F, Zhang T, Kaplan A, Regev MS (2020) Disease-associated astrocytes in Alzheimer’s disease and aging. Nat Neurosci 23:701–706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kirdajova DB, Kriska J, Tureckova J, Anderova M (2020) Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells. Front Cell Neurosci 14:51

    Article  CAS  Google Scholar 

  • Krzyzanowska W, P B, Filip M, Pera J (2014) Glutamate transporters in brain ischemia: to modulate or not? Acta Pharmacol Sin 35:444–462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee JH, Choi SH, Baek MW, Kim MH, Kim HJ, Kim SH, Oh SJ, Park HJ, Kim WJ, Jung JY (2013) CoCl2 induces apoptosis through the mitochondria- and death receptor-mediated pathway in the mouse embryonic stem cells. Mol Cell Biochem 379:133–140

    Article  CAS  PubMed  Google Scholar 

  • Lewis DK, Thomas KT, Selvamani A, Sohrabji F (2012) Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging 33:1123.e1121-1123.e1116

    Article  Google Scholar 

  • Lo EH, Moskowitz MA, Jacobs TP (2005) Exciting, radical, suicidal: how brain cells die after stroke. Stroke 36:189–192

    Article  PubMed  Google Scholar 

  • Marmiroli P, Cavaletti G (2012) The glutamatergic neurotransmission in the central nervous system. Curr Med Chem 19:1269–1276

    Article  CAS  PubMed  Google Scholar 

  • Matute C, Domercq M, Sanchez-Gomez M (2006) Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53:212–224

    Article  PubMed  Google Scholar 

  • Mccarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissues. J Cell Biol 85:890–902

    Article  CAS  PubMed  Google Scholar 

  • Pinky NF, Wilkie CM, Barnes JR, Parsons MP (2018) Region- and activity-dependent regulation of extracellular glutamate. J Neurosci 38:5351–5366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schildge S, Bohrer C, Beck K, Schachtrup C (2013) Isolation and culture of mouse cortical astrocytes. J vis Exp 71:50079

    Google Scholar 

  • Shin EJ, Bach JH, Lee SY, Kim JM, Lee J, Hong JS, Nabeshima T, Kim HC (2011) Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs. J Pharmacol Sci 116:137–148

    Article  CAS  PubMed  Google Scholar 

  • Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35

    Article  PubMed  Google Scholar 

  • Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111–127

    Article  CAS  PubMed  Google Scholar 

  • Umemura K, Gemba T, Mizuno A, Nakashima M (1996) Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion. Stroke 27:1624–1628

    Article  CAS  PubMed  Google Scholar 

  • Volterra A, Trotti D, Racagni G (1994) Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol Pharmacol 46:986–992

    CAS  PubMed  Google Scholar 

  • Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS (2005) 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J 19:395–397

    Article  CAS  PubMed  Google Scholar 

  • Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Zhang W, Hong JS, Kim HC (2006) 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro. FASEB J 20:2496–2511

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (Grant No. 2020R1A2C2011617) and by the Chung-Ang University Research Scholarship Grant in 2020.

Author information

Authors and Affiliations

Authors

Contributions

Ok-Hyeon Kim contributed to investigation, methodology, data curation, and writing—original draft. Gyeong Yun Lee contributed to methodology and writing—original draft. Kyung Yong Kim contributed to conceptualization, investigation and writing—original draft. Jong In Son contributed to investigation and methodology. Tae Woo Jung, Ji Hoon Jeong, Joon Seok Bang, and Hyoung-Chun Kim contributed to conceptualization and investigation. Yoon Hee Chung contributed to conceptualization and methodology. Hyun Jung Lee contributed to conceptualization, investigation, formal analysis, funding acquisition, writing—original draft, and writing—review and editing.

Corresponding author

Correspondence to Hyun Jung Lee.

Ethics declarations

Conflict of interest

Ok-Hyeon Kim declares that she has no conflict of interest. Gyeong Yun Lee declares that he has no conflict of interest. Kyung Yong Kim declares that he has no conflict of interest. Jong In Son declares that he has no conflict of interest. Tae Woo Jung declares that he has no conflict of interest. Ji Hoon Jeong declares that he has no conflict of interest. Joon Seok Bang declares that he has no conflict of interest. Hyoung-Chun Kim declares that he has no conflict of interest. Yoon Hee Chung declares that she has no conflict of interest. Hyun Jung Lee declares that she has no conflict of interest.

Ethical approval

This research was approved by the Institutional Animal Care Use Committee (IACUC) of Chung-Ang University (Approval ID: 202100006).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, OH., Lee, G.Y., Kim, K.Y. et al. 3-Hydroxymorphinan protects against hypoxia-induced cell death in primary astrocyte by regulating Ca2+ influx and the glutamate homeostasis. Mol. Cell. Toxicol. 19, 145–153 (2023). https://doi.org/10.1007/s13273-022-00276-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-022-00276-4

Keywords

Navigation